Baylor College of Medicine;The U.S.A. as represented by the Secretary, Department of Health and Human Services
发明人:
TWEARDY, DAVID J.,KASEMBELI, MOSES M.,XU, MARVIN X.,MILNER, JOSH,BOCCHINI, CLAIRE E.
申请号：
PL14826325
公开号：
PL3021840T3
申请日:
2014.07.18
申请国别(地区):
PL
年份:
2020
代理人:
摘要：
Embodiments of the invention include methods of preventing and/or reducing the risk or severity of an allergic reaction in an individual. In some embodiments, particular small molecules are employed for prevention and/or reduction in the risk or severity of anaphylaxis. In at least particular cases, the small molecules are inhibitors of STAT3. In some cases, the small molecule comprises N-(1&prime；,2-dihydroxy-1,2&prime；-binaphthalen-4&prime；-yl)-4-methoxybenzenesulfonamide.
